Clemens Reinshagen

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Herpes Simplex Virus

Top Venues

Science translational medicine

Science advances

Scientific reports

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan G Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan G Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan G Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan G Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Deepak Bhere, Sung Hugh Choi, Pim van de Donk, David L Hope, Kiki Gortzak, Amina Kunnummal, Jasneet Khalsa, Esther Revai-Lechtich, Clemens Reinshagen, Victoria Leon, Nabil Nissar, Wenya Linda Bi, Cheng Feng, Hongbin Li, Yu Shrike Zhang, Steven H Liang, Neil Vasdev, Walid Ibn Essayed, Pablo Valdes Quevedo, Alexandra Golby, Naima Banouni, Anna Palagina, Reza Abdi, Brian Fury, Stelios Manolis Smirnakis, Alarice Lowe, Brock Reeve, Arthur Hiller, E Antonio Chiocca, Glenn Prestwich, Hiroaki Wakimoto, Gerhard Bauer, Khalid Shah
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nature communications 13 (1) (2022)
Yohei Kitamura, Nobuhiko Kanaya, Susana Moleirinho, Wanlu Du, Clemens Reinshagen, Nada Attia, Agnieszka Bronisz, Esther Revai Lechtich, Hikaru Sasaki, Joana Liliana Mora, Priscilla Kaliopi Brastianos, Jefferey L Falcone, Aldebaran M Hofer, Arnaldo Franco, Khalid Shah
Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Science advances 7 (10) (2021)
Clemens Reinshagen, Deepak Bhere, Sung Hugh Choi, Stefan Hutten, Irina Nesterenko, Hiroaki Wakimoto, Eloi Le Roux, Alia Rizvi, Wanlu Du, Charles Minicucci, Khalid Shah
CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors. Science translational medicine 10 (449) (2019)
Yanni Zhu, Nicole Bassoff, Clemens Reinshagen, Deepak Bhere, Michal O Nowicki, Sean E Lawler, Jérémie Roux, Khalid Shah
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors. Scientific reports 7 (1) (2017)